Review article · 2019 · Open access
Efficiency of phage therapy in humans: systematic review
Journal Infectology, 11(4), 19–30 · Published 8 December 2019 · DOI 10.22625/2072-6732-2019-11-4-19-30
In brief
“Efficiency of phage therapy in humans: systematic review” is a 2019 review article by N. V. Saperkin and 4 co-authors, published in Journal Infectology. OpenAlex counts 4 citations as of 15 November 2026. It is open access under a CC BY licence: the full text is free to read at Journal Infectology.
- Citations
- 4
- Most cited in
- 2022 (2)
- Field-weighted impact
- 0.11
- References
- 19
- Authors
- 5
Abstract
Successful implementation of lytic virulent bacteriophages in clinical practice requires convincing evidence of its safety and efficacy. Design : We searched in CENTRAL, MEDLINE, Embase, and Russian-language literature databases in May 2018. Original articles must fulfill the following eligibility criteria: randomized, controlled trials investigating the effects of phage therapy in people with bacterial infections; at least one patient outcome was reported. Three review authors independently selected, studies, extracted, data, and. assessed, risk of bias. We used, random-effects models for meta-analysis. Participants: adults and. children of both, sexes with bacterial infection, including multi-drug resistant variants, or individuals at risk of infection. Outcomes: recovery or resolution of infection; clinical improvement; change in number of exacerbations; recurrence of infection; quality of life; elimination or load, reduction of a pathogen in an anatomical compartment. Results : We included 13 trials (issued in 1965-2018) including 9 treatment studies and. 4 prevention studies. Overall, eight randomized, trials involved, adults. Five studies addressed skin and soft tissues infections, six studies concerned intestinal infections, one study addressed respiratory tract infection and. one study — ear infection. Across bias domains, 35-90% of trials scored, low risk of bias. Meta-analysis for adverse events attributable to phages and. for wound, healing provided us with pooled relative risks of 0.74 (95% CI 0.68;1.2) and 0.91 (95% CI0.68;1.2) respectively. Conclusions: Beneficial effect of bacteriophages can be demonstrated, and. not refuted. However, our study led. to tentative conclusions. The conduct of well-designed and sufficiently powered, trials would, facilitate registration and. wide accepting of bacteriophage treatment.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Saperkin, N. V., Kovalishena, O. V., Kvashnina, D. V., Ruizendaal, E., & Scholten, R. J. P. M. (2019). Efficiency of phage therapy in humans: systematic review. Journal Infectology, 11(4), 19–30. https://doi.org/10.22625/2072-6732-2019-11-4-19-30
MLA 9
Saperkin, N. V., et al. “Efficiency of phage therapy in humans: systematic review.” Journal Infectology, vol. 11, no. 4, 2019, pp. 19–30. https://doi.org/10.22625/2072-6732-2019-11-4-19-30.
Chicago
Saperkin, N. V., Olga V. Kovalishena, D. V. Kvashnina, Esmée Ruizendaal, and Rob J. P. M. Scholten. 2019. “Efficiency of phage therapy in humans: systematic review.” Journal Infectology 11 (4): 19–30. https://doi.org/10.22625/2072-6732-2019-11-4-19-30.
Harvard
Saperkin, N. V. et al. (2019) ‘Efficiency of phage therapy in humans: systematic review’, Journal Infectology, 11(4), pp. 19–30. doi:10.22625/2072-6732-2019-11-4-19-30.
IEEE
N. V. Saperkin, O. V. Kovalishena, D. V. Kvashnina, E. Ruizendaal, and R. J. P. M. Scholten, “Efficiency of phage therapy in humans: systematic review,” Journal Infectology, vol. 11, no. 4, pp. 19–30, 2019, doi: 10.22625/2072-6732-2019-11-4-19-30.
BibTeX
@article{saperkin2019efficiency,
title = {{Efficiency of phage therapy in humans: systematic review}},
author = {Saperkin, N. V. and Kovalishena, Olga V. and Kvashnina, D. V. and Ruizendaal, Esmée and Scholten, Rob J. P. M.},
journal = {Journal Infectology},
year = {2019},
volume = {11},
number = {4},
pages = {19--30},
doi = {10.22625/2072-6732-2019-11-4-19-30},
url = {https://doi.org/10.22625/2072-6732-2019-11-4-19-30}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2020 | 1 | |
| 2021 | 1 | |
| 2022 | 2 |
Its field-weighted citation impact is 0.11: it has been cited 0.11 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- phage therapy
- lytic phages
- bacterial infection
- multidrug-resistant bacteria
- skin and soft tissue infections
- intestinal infection
- respiratory infections
- ear infection
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Saperkin, N. V., Kovalishena, O. V., Kvashnina, D. V., Ruizendaal, E., & Scholten, R. J. P. M. (2019). Efficiency of phage therapy in humans: systematic review. Journal Infectology, 11(4), 19–30. https://doi.org/10.22625/2072-6732-2019-11-4-19-30
How many times has this paper been cited?
4 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal Infectology.
Who wrote this paper?
N. V. Saperkin, Olga V. Kovalishena, D. V. Kvashnina, Esmée Ruizendaal, Rob J. P. M. Scholten.
What is the DOI of this paper?
10.22625/2072-6732-2019-11-4-19-30. The permanent link is https://doi.org/10.22625/2072-6732-2019-11-4-19-30.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.